Journal info

6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal

Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.


CX3CL1 in the red bone marrow promotes renal cell carcinoma to metastasize to the spine by involving the Src-related pathway
Authors: An-Nan Hu, Fan-Cheng Chen, Ke-Tao Wang, Zhen-Qing Wang, Yun Liang, Jian Dong
Neoplasma Vol.69, No.3, p.670–679, 2022
Price: free access
[View Abstract]

CDC Like Kinase 2 plays an oncogenic role in colorectal cancer via modulating the Wnt/β-catenin signaling
Authors: Hai-Bo Zhou, Li Yang, Shi-Fang Liu, Xin-Hua Xu, Zhuo Chen, Yun-Xiao Li, Jin-Hua Yuan, Yong-Chang Wei
Neoplasma Vol.69, No.3, p.657–669, 2022
Price: free access
[View Abstract]

Co-treatment of betulin and gefitinib is effective against EGFR wild-type/KRAS-mutant non-small cell lung cancer by inducing ferroptosis
Authors: Wei-Ya Yan, Jian Cai, Jiang-Nan Wang, Yong-Sheng Gong, Xue-Bing Ding
Neoplasma Vol.69, No.3, p.648–656, 2022
Price: free access
[View Abstract]

ARHGAP17 enhances 5-Fluorouracil-induced apoptosis in colon cancer cells by suppressing Rac1
Authors: Sheng-Li Pan, Ying-Ying Deng, Jun Fu, Yu-Hao Zhang, Zhi-Jin Zhang, Xian-Ju Qin
Neoplasma Vol.69, No.3, p.640–647, 2022
Price: free access
[View Abstract]

Glucose and glutamine metabolism-related protein expression in breast ductal carcinoma in situ
Authors: Hyang Joo Ryu, Ja Seung Koo
Neoplasma Vol.69, No.3, p.630–639, 2022
Price: free access
[View Abstract]

Iodine-125 induced cholangiocarcinoma cell death is enhanced by inhibition of endoplasmic reticulum stress-mediated protective autophagy
Authors: Lei Zou, Wei Chang, Jian-Hua Bai, Wan-Hong Shi, Yun Jin, Jun-Feng Wang, Kun-Hua Wang
Neoplasma Vol.69, No.3, p.620–629, 2022
Price: free access
[View Abstract]

Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signaling pathway
Authors: Zhi-Qiang Zhang, Wen-Liang Xuan, Yang Huang, Shuo Ren, Tu-Ya Wulan, Ye Song, Dong-Bo Xue, Wei-Hui Zhang
Neoplasma Vol.69, No.3, p.603–619, 2022
Price: free access
[View Abstract]

LncRNA NEAT1-associated aerobic glycolysis blunts tumor immunosurveillance by T cells in prostate cancer
Authors: Kai-Guo Xia, Chang-Ming Wang, De-Yun Shen, Xiao-Yuan Song, Xiang-Yu Mu, Jia-Wei Zhou, An-Yang Zhu, Qiang Xuan, Tao Tao
Neoplasma Vol.69, No.3, p.594–602, 2022
Price: free access
[View Abstract]

LncRNA BCYRN1 promotes cell migration and invasion of non-small cell lung cancer via the miR-30b-3p/ROCK1 axis
Authors: Shu Song, Wei-Gang Bian, Zhu Qin, Dong Zeng, Jing-Jing Xu, Hai-Cheng Tang
Neoplasma Vol.69, No.3, p.583–593, 2022
Price: free access
[View Abstract]

Skimmianine as a novel therapeutic agent suppresses proliferation and migration of human esophageal squamous cell carcinoma via blocking the activation of ERK1/2
Authors: Yang Liu, Lin Kang, Shao-Min Shi, Bing-Jie Li, Yang Zhang, Xiu-Zhi Zhang, Xiao-Wan Guo, Gang Fu, Guo-Na Zheng, Han Hao, Huan-Fen Zhao
Neoplasma Vol.69, No.3, p.571–582, 2022
Price: free access
[View Abstract]

sh-HNF1A-AS1 reduces the epithelial-mesenchymal transition and stemness of esophageal cancer cells
Authors: Zheng Wang, Yan-Feng Huang, Ling Yu, Yue Jiao
Neoplasma Vol.69, No.3, p.560–570, 2022
Price: free access
[View Abstract]

Elevation of miR-125b-5p is related to improved prognosis in laryngeal squamous cell carcinoma and inhibits the malignancy and glycometabolic disorder by targeting MAP3K9
Authors: Fu Chen, Zheng Lao, Hai-Yan Zhang, Jie Wang, Sheng-Zi Wang
Neoplasma Vol.69, No.3, p.550–559, 2022
Price: free access
[View Abstract]

Tumor suppressive lncRNA MEG3 binds to EZH2 and enhances CXCL3 methylation in gallbladder cancer
Authors: De-Qiang Li, Yi-Ren Ding, Jin-Hui Che, Zhan Su, Wei-Zhong Yang, Lu Xu, Yun-Jiu Li, Hai-Hong Wang, Wu-Yuan Zhou
Neoplasma Vol.69, No.3, p.538–549, 2022
Price: free access
[View Abstract]

Identification of circRNAs involved in the development of hepatocellular carcinoma after insufficient radiofrequency ablation
Authors: Jun-Wei Chen, Li-Sha Lai, Jun-Yang Luo, Chu-Ren Zhou, Min-Gan Li, Ming-Sheng Huang, Ping Wu
Neoplasma Vol.69, No.3, p.527–537, 2022
Price: free access
[View Abstract]

Exosomal circRNAs as novel potential biomarkers for colorectal adenoma
Authors: Shaobing Cheng, Sen Lu, Fanlong Liu
Neoplasma Vol.69, No.3, p.516–526, 2022
Price: free access
[View Abstract]

Drug therapy for bone metastasis of malignant tumor: theory, progress, and potential
Authors: Ji-Zheng Tian, Ni-Na Ma, Xiao Li, Kun Shang, Bang-Wei Cao
Neoplasma Vol.69, No.3, p.504–515, 2022
Price: free access
[View Abstract]

Periostin: a predictable molecule to prognosis and chemotherapy responses of gastrointestinal and hepato-biliary-pancreatic malignant tumors?
Authors: Wei Zhang, Fa-Hong Wu, Jia Wang, Hang-Zhi Wei, Tian-Wei Wang, You-Cheng Zhang
Neoplasma Vol.69, No.3, p.491–503, 2022
Price: free access
[View Abstract]

Clinicopathological characteristics and prognosis of breast cancer patients with lung cancer: A study based on 19,807 breast cancer patients
Authors: Jin-Zhao Liu, Wei-Fang Zhang, Xiao-Fei Ren, Geng Zhang, Chao Yang, Shuo Zhang, Xiang-Mei Zhang, Yun-Jiang Liu
Neoplasma Vol.69, No.2, p.484–490, 2022
Price: free access
[View Abstract]

Novel biochemical markers for non-invasive detection of pancreatic cancer
Authors: Pavel Hrabák, Jan Šoupal, Marta Kalousová, Tomáš Krechler, Michal Vočka, Tomáš Hanuš, Luboš Petruželka, Štěpán Svačina, Aleš Žák, Tomáš Zima
Neoplasma Vol.69, No.2, p.474–483, 2022
Price: free access
[View Abstract]

Exploring the prognosis of neuroblastoma in adolescents and adults: a case series and literature review
Authors: Qian-Ya Jin, Shi-Bei Du, Xiao-Jun Yuan
Neoplasma Vol.69, No.2, p.464–473, 2022
Price: free access
[View Abstract]

Display #  
Results 81 - 100 of 145

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.